Evidence map›Paper›PMID 39819731›Full record

ArticleTranslational neurodegeneration2025

Cerebrospinal fluid cyclase-associated protein 2 is increased in Alzheimer's disease and correlates with tau pathology.

Alessandro Padovani, Andrea Pilotto, Silvia Pelucchi, Laura D'Andrea, Ramona Stringhi, Federica Gorla, Bahar Aksan, Salvatore Caratozzolo, Alberto Benussi, Alice Galli and 7 more

Abstract readLetter
In one paragraph

Article in Translational neurodegeneration, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Alessandro Padovani *Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. Alessandro.padovani@unibs.it.
Andrea Pilotto *Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. andrea.pilotto@unibs.it.ORCID http://orcid.org/0000-0003-2029-6606
Silvia PelucchiDepartment of Pharmacological and Biomolecular Sciences, Rodolfo Paoletti", Università Degli Studi Di Milano, Milan, Italy.
Laura D'AndreaDepartment of Pharmacological and Biomolecular Sciences, Rodolfo Paoletti", Università Degli Studi Di Milano, Milan, Italy.
Ramona StringhiDepartment of Pharmacological and Biomolecular Sciences, Rodolfo Paoletti", Università Degli Studi Di Milano, Milan, Italy.
Federica GorlaDepartment of Pharmacological and Biomolecular Sciences, Rodolfo Paoletti", Università Degli Studi Di Milano, Milan, Italy.
Bahar AksanDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany.
Salvatore CaratozzoloNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Alberto BenussiNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Alice GalliNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Clara TirloniNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Daniela MauceriDepartment of Neurobiology, Interdisciplinary Centre for Neurosciences (IZN), Heidelberg University, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany.
Antonio CanaleDepartment of Statistical Sciences, University of Padova, Padua, Italy.
Silvana ArchettiIII Laboratory of Analyses, Brescia Hospital, Brescia, Italy.
Barbara BorroniNeurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Monica Di LucaDepartment of Pharmacological and Biomolecular Sciences, Rodolfo Paoletti", Università Degli Studi Di Milano, Milan, Italy.
Elena MarcelloDepartment of Pharmacological and Biomolecular Sciences, Rodolfo Paoletti", Università Degli Studi Di Milano, Milan, Italy.

Funding

Alzheimer Forschung Initiative 21019Associazione Italiana Ricerca Alzheimer AGYR2021 Life-BioAssociazione Italiana Ricerca Alzheimer AHA MCADeutsche Forschungsgemeinschaft SFB1158 project A08Fondazione Cariplo 2021-1516Ministero della Salute PNRR-MAD-2022-12376110Ministero della Salute PNRR P2022TKN8CMinistero della Salute PRIN 20202THZAWMinistero della Salute RF-2018-12366209Ministero dell'Istruzione, dell'Università e della Ricerca 2017MYJ5THMinistero dell'Istruzione, dell'Università e della Ricerca FIS00000560 - StoneMinistero dell'Istruzione, dell'Università e della Ricerca H2020 IMI IDEA-FAST ID853981Ministero dell'Istruzione, dell'Università e della Ricerca ID853981Ministero dell'Istruzione, dell'Università e della Ricerca PNRR miss 4.2- investimento 1.3Ministero dell'Istruzione, dell'Università e della Ricerca PNRR P2022R2E8NMinistero dell'Istruzione, dell'Università e della Ricerca PRIN202039WMFP
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39819731
PMCPMC11736935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.